Eris Lifesciences Limited
Listed as ERIS: its shares held by funds are on the stock page.
% of scheme: the share of the scheme's net assets, as the fund house states it. Sep 2026: "—" = no Sep 2026 portfolio from that fund house.
| Security | Grade or sector, as printed | Held | Schemes |
|---|---|---|---|
| Eris Lifesciences Ltd. Bond / debenture · INE406M08011 | IND AA / FITCH AA / IND-AA | ₹492 cr | 15 |
| Eris Lifesciences Ltd. ** Bond / debenture · INE406M08029 | FITCH AA / IND AA / IND-AA | ₹396 cr | 9 |
Name, and the credit agency grade (or a sector, where the fund house prints one), as the fund houses print them: several spellings, the most common; several grades, all of them, most common first. This site gives no view on credit.
| Month | Held | Schemes | Fund houses holding / covered |
|---|---|---|---|
| Oct 2026 | ₹888 cr | 18 | 6 / 38 |
| Sep 2026 | ₹891 cr | 15 | 5 / 38 |
| Aug 2026 | ₹892 cr | 15 | 5 / 37 |
| Jul 2026 | ₹892 cr | 15 | 5 / 39 |
| Jun 2026 | ₹894 cr | 15 | 5 / 38 |
| May 2026 | ₹815 cr | 13 | 4 / 39 |
| Apr 2026 | ₹818 cr | 13 | 4 / 39 |
| Mar 2026 | ₹893 cr | 15 | 5 / 39 |
| Feb 2026 | ₹896 cr | 15 | 5 / 42 |
| Jan 2026 | ₹895 cr | 15 | 5 / 41 |
| Dec 2025 | ₹969 cr | 15 | 5 / 41 |
| Nov 2025 | ₹896 cr | 13 | 4 / 40 |
| Oct 2025 | ₹897 cr | 13 | 4 / 38 |
| Sep 2025 | ₹1,038 cr | 13 | 4 / 33 |
A month with fewer fund houses covered is not comparable in full with one with more. Bonds, debentures, commercial paper, certificates of deposit, securitised debt and preference shares a company, bank or trust issued, as each fund house lists them in its monthly portfolio. Government securities, REIT/InvIT units and fund units are not included. Credit agency grades are copied as the fund house prints them; this site gives no view on credit. Not investment advice.